Chronic PainTreatmentsMedicationFAQsLinks
Chronic Disorders
Know the difference between physical dependence and addiction. Unreasonable fears about addiction should not be why patients refuse opioid therapy.

     Find a Pain Specialist

Opioid Analgesics
Print Page

About Opioids
Physical Dependence, Addiction, and Tolerance
Opioid Treatment Guidelines

About Opioids

The most effective analgesics by far are the opioid analgesics. The opioids include all drugs that interact with opioid receptors in the nervous system. These receptors are the sites of action for the endorphins, compounds that already exist in the body and are chemically related to the opioid drugs that are prescribed for pain.

The opioids consist of several classes. The so-called antagonists have no analgesic effect and are used to block the effects of opioid drugs. In the clinical setting, antagonist drugs are used to reverse opioid toxicity, typically from overdose. They are also being investigated as a treatment for opioid-induced constipation. One antagonist drug, naltrexone, is also used to treat alcohol addiction.

The antagonist drugs include:

Naloxone (Narcan™)
Naltrexone (Trexan™)
Nalmafene (Revex™)

The so-called agonist-antagonist drugs have a relationship to the opioid receptors that includes activation and blockade. Some of these drugs activate one type of opioid receptor, known as the kappa receptor, while blocking another, the mu receptor. Others just interact with the mu receptor and activate it until the dose is increased to a certain point, at which the activation effect plateaus and then drops. These drugs are sometimes used to treat acute pain or headache. One of these drugs, buprenorphine, is also being used to treat opioid addiction.

The agonist-antagonist class includes:

Buprenorphine (Buprenex™)
Butorphanol (Stadol™)
Nalbuphine (Nubain™)
Dezocine (Dalgan™)

The agonist-antagonist opioid class have several disadvantages when compared to the major class of opioid analgesics, the pure mu agonists. All of these drugs have a ceiling effect, meaning that there is a dose above which higher doses produce no additional pain relief. None of them can be given to patients who are already receiving another opioid because they can, in some of these circumstances, produce withdrawal. Finally, some of the agonist-antagonist drugs tend to produce more confusion than the pure mu agonist class. In short, these drugs can be used to treat acute or chronic pain but there are no definite advantages in most patients when compared to the pure mu agonists and there are some potential disadvantages to consider.

The pure mu agonist class include a large number of specific drugs, some of which are available in combination with aspirin, acetaminophen or ibuprofen, and some of which are available in extended-release formulations. Historically, these drugs have been the mainstay approach for the short-term management of acute severe pain and for the long-term management of moderate-to-severe pain related to cancer and other life-threatening illnesses. During the past fifteen years, there has been an evolving acceptance of long-term treatment for selected patients with severe chronic pain of other types.

The pure mu agonists include:

Short-acting oral drugs that may be combined with a nonopioid drug and are typically prescribed for acute pain in the outpatient setting. This group includes codeine, hydrocodone, oxycodone, and others.
Short-acting drugs that may be given intravenously, subcutaneously or intramuscularly and are usually administered for acute pain in the inpatient setting. This group includes morphine, meperidine, hydromorphone, fentanyl, and others.
Long-acting drugs that are usually administered in the outpatient setting for the long-term management of chronic pain. This group includes extended-release oral morphine, extended-release oral oxycodone, extended-release oral hydromorphone, extended-release transdermal (via a skin patch) fentanyl, and methadone.

All the pure mu agonist drugs share some characteristics. First, there is no ceiling dose. In most cases, pain is relieved more and more as the dose is increased, until side effects limit therapy. Patients who develop intolerable side effects without achieving satisfactory analgesia are called "poorly responsive" to the specific drug.

All of the pure mu agonist drugs have the same potential for side effects, but individual patients vary a great deal in the specific side effects experienced and the pain relief that will occur before side effects become a problem. This variability from patient to patient means that the responsiveness of individuals to the various opioid drugs varies. For example, some patients have better effects from morphine than oxycodone, and some are just the opposite.

The side effects associated with the opioid drugs include the following:

Constipation. This is very common and is often a persistent problem.
Nausea. This may occur at the start of therapy. It usually passes after a short time.
Sleepiness, fatigue, dizziness and mental clouding. These are common at the start of therapy and usually pass after a short while.
Itch
Urinary retention
Dry mouth
Sexual dysfunction

Opioid drugs can cause breathing to slow and, in overdose, can be lethal. Breathing problems of this type are very rare when these drugs are administered in an appropriate way.

Opioids can potentially be used, either short-term or long-term, for any severe pain. They are widely accepted as the preferred treatment for acute pain and chronic pain associated with cancer. Although the use of opioid drugs on a long-term basis to treat chronic noncancer pain is still controversial, pain specialists now agree that selected patients can benefit. When used appropriately, these patients can experience sustained pain relief with tolerable side effects and little risk of ever developing addiction. As pain relief improves, patients may be able to function better and experience a much improved quality of life.

Some of the key principles that apply to these drugs include the following:

Selecting the Therapy. Opioids are typically first-line if the pain is severe and is expected to be short-lived, like post-surgical pain, and if the pain is associated with a progressive incurable illness. In other types of chronic pain, a decision to try an opioid should be based on a careful evaluation by the clinician. This evaluation should try to answer several questions: Is the pain severe enough to warrant this therapy? Are there other therapies just as safe as the opioids that might work as well or better? Is the use of an opioid complicated by some medical problem that makes them relatively less safe? Is this patient likely to be responsible with these drugs, or is there some indication that drug-taking behaviors might become a problem?

Individualize the Therapy. For short-term therapy, a short-acting drug is usually selected. For longer term therapy, a long-acting drug is preferred. Whatever drug is selected, the key to successful therapy is gradual adjustment of the dose until a favorable balance between pain relief and side effects is attained. If this favorable balance is not possible with one drug, a switch to another opioid might be considered.

Treat Side Effects. Many patients will need treatment for constipation during therapy. Some will need a medicine for nausea. During long-term therapy, some physicians will administer a stimulant drug if the pain control is good but therapy is compromised by sleepiness, fatigue or mental clouding.

Consider Other Therapies. Patients with chronic pain often do best when one or more pain-relieving drugs are combined with other therapies, including rehabilitative approaches, psychological therapies, injections, or CAM approaches.

Follow the Appropriate Outcomes. There are four types of outcomes that should be monitored by the physician prescribing an opioid therapy:
  1. pain relief,
  2. side effects,
  3. physical and psychosocial functioning, and
  4. the occurrence of any aberrant drug-related behaviors.
Patients should be made aware by their prescribers that there are a wide variety of side effects possible with the use of these medications. It is important that patients talk with their providers about any changes they have noticed in any area of their lives since beginning a new treatment regimen. Patients can help by being prepared to discuss these outcomes with the prescriber.




Physical Dependence, Addiction, and Tolerance

As more doctors begin to consider a trial of opioid therapy for patients with chronic noncancer pain, the need to eliminate the stigma, the myths, and the misconceptions that surround these drugs is a priority. Pain specialists have been working toward this goal. The following are some key points about opioid therapy:

Many people confuse physical dependence, which is the occurrence of withdrawal when the drug is stopped, with addiction. Withdrawal is a physical phenomenon that means that the body has adapted to the drug in such a way that a "rebound" occurs when the drug is suddenly stopped. The kind of symptoms that occur include rapid pulse, sweating, nausea and vomiting, diarrhea, runny nose, "gooseflesh," and anxiety. All people who take opioids for a period of time can potentially have this withdrawal syndrome if the drug is stopped or the dose is suddenly lowered. This is not a problem as long as it is prevented by avoiding sudden reductions in the dose.

Physical dependence is entirely different from addiction. Addiction is defined by a loss of control over the drug, compulsive use of the drug, and continued use of the drug even if it is harming the person or others. People who become addicted often deny that they have a problem, even as they desperately try to maintain the supply of the drug.

Addiction is a "biopsychosocial" disease. This means that most people who become addicted to drugs are probably predisposed (it is in the genes) but only develop the problem if they have access to the drug and take it at a time and in a way that leaves them vulnerable. A very large experience in the treatment of patients with chronic pain indicates that the risk of addiction among people with no prior history of substance abuse who are given an opioid for pain is very low. The history of substance abuse doesn't mean that a patient should never get an opioid for pain, but does suggest that the doctor must be very cautious when prescribing and monitoring this therapy.

People with chronic pain should understand the difference between physical dependence and addiction. Unreasonable fears about addiction should not be the reason that doctors refuse this therapy or patients refuse to take it.

Tolerance to opioid drugs occurs but is seldom a clinical problem. Tolerance means that taking the drug changes the body in such a way that the drug loses its effect over time. If the effect that is lost is a side effect, like sleepiness, tolerance is a good thing. If the effect is pain relief, tolerance is a problem. Fortunately, a very large experience indicates that most patients can reach a favorable balance between pain relief and side effects then stabilize at this dose for a long period of time. If doses need to be increased because pain returns, it is more commonly due to worsening of the painful disease than it is to tolerance.

Although opioids can make people sleepy and cloud their thinking, this side effect is usually temporary and long-term therapy is usually associated with normal thinking. Many people fear that taking an opioid will cause them to become "a zombie," unable to function even if the pain is relieved. Fortunately, this is not the case. Most patients can take these drugs for a long period of time and be mentally normal. Patients who have been stabilized on opioid therapy and are clearheaded can drive, work, and do whatever else is necessary.

Opioid drugs are not a cure-all. Although pain specialists now believe that many patients can benefit from this therapy, they also recognize that some patients do poorly. Some patients experience sleepiness or mental clouding that never clears, and still others develop persistent nausea or severe constipation. Some patients actually do not function well when treated with these drugs. Finally, some cannot be responsible drug takers; rarely, a true addiction develops.

For all these reasons, chronic opioid therapy is generally not a first-line treatment for patients with persistent pain. Each patient who is a possible candidate should be evaluated by a professional who is knowledgeable about the use of this therapy.

Patients who receive a trial of an opioid drug should expect to be carefully monitored by their physicians. Any patient given opioid drugs to treat pain should follow the doctor's prescription exactly. Patients should never increase the dose on their own. They should never go to another physician to get prescriptions and should always be completely honest in reporting the effects produced by the drug.

The physician will inquire about pain relief; side effects; the ability to function physically, psychologically and socially; and the occurrence of any behavior that suggests problems in controlling the medication. For some patients, very intensive monitoring is appropriate; for others, monitoring can be less intensive.

Some doctors will want the patient to agree to a contract that describes the patient's responsibilities when taking the drug. Some physicians will even want to monitor the patient's urine to make sure that the patient is taking only the drugs that should be taken. A physician may want these things to feel secure in the knowledge that the patient is appropriately using the drug. When the physician is able to have this security, he or she is free to act in the patient's best interests. A good relationship between the physician and patient is needed for long term opioid therapy to be successful.

The drugs that are now used to treat chronic pain include morphine, hydromorphone, oxycodone, fentanyl, methadone and others. Some opioids, like codeine and hydrocodone, are usually prescribed in combination with acetaminophen or aspirin. Although the latter drugs are sometimes used for chronic pain, long-acting drugs are generally preferred. These long-acting drugs can be taken twice a day, once a day or, in the case of the fentanyl, by patch.

Although some people believe that opioid drugs are only appropriate for certain kinds of pain, doctors are unable to accurately predict which pain problems will not respond.

Each opioid produces a different range of effects in each individual. The same person may get too sleepy from morphine but experience very little sleepiness from oxycodone, or vice versa. For this reason, many pain specialists are now suggesting that patients with chronic noncancer pain be given an opportunity to try different commercially available opioid drugs in order to find the drug that produces the most favorable balance between pain relief and side effects.

Regardless of the opioid, the dose often has to be adjusted to get the best effect. Patients should understand that adjustment of the dose and the use of other medicines, like laxatives, to treat side effects are a common part of therapy.




Clinical Guidelines

View recent treatment guidelines for the use of opioid therapy in chronic noncancer pain:
Opioid Treatment Guidelines (.pdf) - The Journal of Pain, Vol 10, No 2 (February), 2009: pp 113-130





For more information about chemical dependency, see our Pain and Chemical Dependency pages.



Home | Contact Us | Privacy Policy | Disclaimer | Site Map
This website is funded by your generous support. Care to Donate?
©2000-2011 Continuum Health Partners, Inc.

 
Visit other Stoppain.org sites Print This Page Home Home